Peptide record

TPDB06827

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity standard
12 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB06827
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia Antifungipept CAFPdb APD_complete APD_hemolytic HemoPI Hemolytic2 PD_Hemolysis ToxinPred 3.0
standard
No
A 12-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GLLSGTSVRGSI
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C48H87N15O17
ANDCEQHKMFPWY
GS
1146.31
11.05
1
0
4
+1
0.51
0.625
121.67
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
4
Residue Composition
number
0
A
1
R
0
N
0
D
0
C
0
E
0
Q
3
G
0
H
1
I
2
L
0
K
0
M
0
F
0
P
3
S
1
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 0 R: 1 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 3 H: 0 I: 1 L: 2 K: 0 M: 0 F: 0 P: 0 S: 3 T: 1 W: 0 Y: 0 V: 1
Chemical Descriptors
12 reviewed residue count
C48H87N15O17 sequence-only estimate (linear, free termini)
1146.31 sequence-only estimate (linear, free termini)
11.05 sequence-only estimate (linear, free termini)
+1 sequence-only estimate (linear, free termini)
0.51 sequence-only estimate (linear, free termini)
0.625 sequence-only estimate (linear, free termini)
Evidence Records 21 records
Evidence 1 Activity

Activity

MIC
Antibacterial
36 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
active against E. coli (MIC 36 ug/ml), S. aureus (MIC 18 ug/ml), B. subtilis (MIC 18 ug/ml), and C. albicans (MIC 9 ug/ml).
Evidence 2 Activity

Activity

MIC
Antibacterial
18 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP

Other

active against E. coli (MIC 36 ug/ml), S. aureus (MIC 18 ug/ml), B. subtilis (MIC 18 ug/ml), and C. albicans (MIC 9 ug/ml).
Evidence 3 Activity

Activity

MIC
Antibacterial
18 µg/mL

Target

B. subtilis

Source & Reference

dbAMP DRAMP

Other

active against E. coli (MIC 36 ug/ml), S. aureus (MIC 18 ug/ml), B. subtilis (MIC 18 ug/ml), and C. albicans (MIC 9 ug/ml).
Evidence 4 Activity

Activity

MIC
Antibacterial
9 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP

Other

against E. coli (MIC 36 ug/ml), S. aureus (MIC 18 ug/ml), B. subtilis (MIC 18 ug/ml), and C. albicans (MIC 9 ug/ml).
Evidence 5 Activity

Activity

MIC
Antifungal
36 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
active against E. coli (MIC 36 ug/ml), S. aureus (MIC 18 ug/ml), B. subtilis (MIC 18 ug/ml), and C. albicans (MIC 9 ug/ml).
Evidence 6 Activity

Activity

MIC
Antifungal
18 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

active against E. coli (MIC 36 ug/ml), S. aureus (MIC 18 ug/ml), B. subtilis (MIC 18 ug/ml), and C. albicans (MIC 9 ug/ml).
Evidence 7 Activity

Activity

MIC
Antifungal
18 µg/mL

Target

B. subtilis

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

active against E. coli (MIC 36 ug/ml), S. aureus (MIC 18 ug/ml), B. subtilis (MIC 18 ug/ml), and C. albicans (MIC 9 ug/ml).
Evidence 8 Activity

Activity

MIC
Antifungal
9 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

against E. coli (MIC 36 ug/ml), S. aureus (MIC 18 ug/ml), B. subtilis (MIC 18 ug/ml), and C. albicans (MIC 9 ug/ml).
Evidence 9 Activity

Activity

MIC
Antiparasitic
36 µg/mL

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
active against E. coli (MIC 36 ug/ml), S. aureus (MIC 18 ug/ml), B. subtilis (MIC 18 ug/ml), and C. albicans (MIC 9 ug/ml).
Evidence 10 Activity

Activity

MIC
Antiparasitic
18 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

active against E. coli (MIC 36 ug/ml), S. aureus (MIC 18 ug/ml), B. subtilis (MIC 18 ug/ml), and C. albicans (MIC 9 ug/ml).
Evidence 11 Activity

Activity

MIC
Antiparasitic
18 µg/mL

Target

B. subtilis

Source & Reference

DRAMP

Other

active against E. coli (MIC 36 ug/ml), S. aureus (MIC 18 ug/ml), B. subtilis (MIC 18 ug/ml), and C. albicans (MIC 9 ug/ml).
Evidence 12 Activity

Activity

MIC
Antiparasitic
9 µg/mL

Target

Candida albicans

Source & Reference

DRAMP

Other

against E. coli (MIC 36 ug/ml), S. aureus (MIC 18 ug/ml), B. subtilis (MIC 18 ug/ml), and C. albicans (MIC 9 ug/ml).
Evidence 13 Activity

Activity

MIC
Antiviral
36 µg/mL

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
active against E. coli (MIC 36 ug/ml), S. aureus (MIC 18 ug/ml), B. subtilis (MIC 18 ug/ml), and C. albicans (MIC 9 ug/ml).
Evidence 14 Activity

Activity

MIC
Antiviral
18 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

active against E. coli (MIC 36 ug/ml), S. aureus (MIC 18 ug/ml), B. subtilis (MIC 18 ug/ml), and C. albicans (MIC 9 ug/ml).
Evidence 15 Activity

Activity

MIC
Antiviral
18 µg/mL

Target

B. subtilis

Source & Reference

DRAMP

Other

active against E. coli (MIC 36 ug/ml), S. aureus (MIC 18 ug/ml), B. subtilis (MIC 18 ug/ml), and C. albicans (MIC 9 ug/ml).
Evidence 16 Activity

Activity

MIC
Antiviral
9 µg/mL

Target

Candida albicans

Source & Reference

DRAMP

Other

against E. coli (MIC 36 ug/ml), S. aureus (MIC 18 ug/ml), B. subtilis (MIC 18 ug/ml), and C. albicans (MIC 9 ug/ml).
Evidence 17 Activity

Activity

% Hemolysis
Hemolysis
4.7 %
[Ref.17272268] RCH=23.9 ± 4.7% against rabbit red blood cells. RCH, red cell hemolysis.

Target

rabbit red blood cells

Source & Reference

Hemolytik APD_complete APD_hemolytic PD_Hemolysis
DRAMP4
Mol Cell Proteomics. 2007 May 6(5):882-894.

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation. Hemolytik experimentally validated hemolytic peptide annotation.
Evidence 18 Activity

Activity

24% Hemolysis
Toxicity
50 µg/mL
Hemolytic Cytotoxic
24% Hemolysis | 50 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Anti-infection peptidomics of amphibian skin. | Mol Cell Proteomics | 2007
Evidence 19 Activity

Activity

(15.5±7.3)% degranulation
Toxicity
50 µg/mL
Cytotoxic
(15.5±7.3)% degranulation | 50 | µg/mL | target cell: Human mast cells

Target

Human mast cells

Source & Reference

NA
DBAASP
Anti-infection peptidomics of amphibian skin. | Mol Cell Proteomics | 2007
Evidence 20 Activity

Activity

Toxicity
Hemolytic
Hemolytic_activity: [Ref.17272268] RCH=23.9 ± 4.7% against rabbit red blood cells. RCH, red cell hemolysis.

Target

erythrocytes

Source & Reference

NA
DRAMP
Mol Cell Proteomics. 2007 May 6(5):882-894.
Evidence 21 Hemolysis

Activity

4.7 %
% Hemolysis
[Ref.17272268] RCH=23.9 ± 4.7% against rabbit red blood cells. RCH, red cell hemolysis.
Hemolysis

Target

rabbit red blood cells

Source & Reference

APD_complete APD_hemolytic HemoPI PD_Hemolysis
Mol Cell Proteomics. 2007 May 6(5):882-894.
DRAMP4
APD_complete APD_hemolytic PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation.